The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.

Voydeya Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for hematologists and prescribers on Voydeya (danicopan) access barriers in 2026: REMS, prior auth, and strategies to minimize patient delays.

Vuity Availability: What Providers and Prescribers Need to Know in 2026
A clinical overview for ophthalmologists and optometrists: Vuity supply chain status, dispensing challenges, patient access strategies, and 2026 landscape updates.

Vyleesi Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on Vyleesi (bremelanotide) access challenges in 2026: specialty distribution, PA requirements, cost programs, and patient support tools.

Westhroid Shortage: What Providers and Prescribers Need to Know in 2026
Westhroid has been largely unavailable since 2020. Here's a concise clinical guide for providers managing patients who depend on this desiccated thyroid brand.
37,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.

Xeljanz XR Access Issues: What Providers and Prescribers Need to Know in 2026
A clinical reference for providers on Xeljanz XR prior authorization, step therapy requirements, safety monitoring, and helping patients navigate access barriers in 2026.

Xigduo XR Shortage: What Providers and Prescribers Need to Know in 2026
Clinicians prescribing Xigduo XR face availability and insurance challenges in 2026. Here's a clinical overview of the situation, therapeutic alternatives, and patient management guidance.

Yasmin 28 Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for providers on Yasmin 28 availability in 2026: current FDA status, prescribing tips, therapeutic substitutions, and patient communication strategies.

Yaz 28 Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for prescribers on Yaz 28 availability in 2026: current supply status, therapeutic alternatives, prescribing strategies, and patient communication tips.

Yusimry Shortage: What Providers and Prescribers Need to Know in 2026
A clinical and logistical overview of Yusimry (adalimumab-aqvh) availability challenges in 2026 for physicians, NPs, PAs, and other prescribers managing patients on biologics.

Zafemy Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for prescribers on Zafemy availability challenges in 2026 — including therapeutic equivalents, patient counseling strategies, and formulary considerations.

Zarontin Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on Zarontin (ethosuximide) availability in 2026. Includes shortage context, prescribing implications, clinical alternatives, and patient support tools.

Zenatane Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on Zenatane (isotretinoin) availability in 2026: iPLEDGE logistics, prescribing strategies, and tools to help your patients fill their prescriptions.